STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own. Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as…
ImpactNotable 33/100
Why it mattersRule-based estimate: no strong signals; trust 8/10.
RegionsGlobal
Published3 h ago (Mon, 28 Sep 2026 08:30:00 GMT)
RetrievedMon, 28 Sep 2026 10:00:46 GMT via rss
ClassifiedMon, 28 Sep 2026 10:00:58 GMT by heuristic
AuthorElaine Chen